FIELD: pharmacology.
SUBSTANCE: invention relates to an antiarrhythmic drug based on lapakonitin alkaloid, which is a pharmaceutical combination comprising lappaconitin, glycyrrhizic acid and methyluracil at a certain molar ratio of components.
EFFECT: agent is an effective antiarrhythmic drug, it can be used for prevention and treatment of atrial and ventricular, including malignant, cardiac arrhythmias.
10 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC AGENT FOR TREATMENT OF DIFFERENT FORMS OF HEART RHYTHM DISTURBANCES | 2000 |
|
RU2180583C1 |
MEANS WITH ANTIARRHYTHMIC ACTION | 2016 |
|
RU2630967C1 |
N-(BETA-HYDROXYETHYL)-CYTISINE HYDROCHLORIDE ELICITING ANTI-ARRHYTHMIC ACTIVITY | 2002 |
|
RU2228179C2 |
NON-6-ENE HYDROCHLORIDE ELICITING ANTI-ARRHYTHMIC ACTIVITY | 2002 |
|
RU2228334C2 |
5-AMINO-EXO-3-AZATRICYCLO[5.2.1.0]-DECAN-4-ONE HAVING ANTI-ARRHYTHMIC, ANTI-INFLAMMATION, ANALGESIC, AND NOOTHROPIC ACTIVITY | 2005 |
|
RU2281938C1 |
METHOD FOR PREVENTION OF CARDIAC RHYTHM DISTURBANCE IN CORONARY BYPASS | 2009 |
|
RU2392939C1 |
DRUG PREPARATION FOR TREATING CARDIAC ARRHYTHMIA | 2013 |
|
RU2513580C1 |
5'-BROMOLAPPACONITINE HYDROBROMIDE POSSESSING ANTI-ARRHYTHMIC ACTIVITY | 2005 |
|
RU2295524C1 |
AGENT POSSESSING ANTIARRHYTHMIC, ANTIFIBRILLATORY, ANTI-ISCHEMIC ACTION, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477130C1 |
AGENT EXHIBITING ANTIARRHYTHMIC ACTIVITY | 2014 |
|
RU2565404C1 |
Authors
Dates
2018-08-21—Published
2017-03-15—Filed